[1]
“Impact of Xerosis in Patients With Cancer Receiving Epidermal Growth Factor Receptor or Mitogen-Activated Protein Kinase Inhibitors: ATIXI, A Non-Interventional, Prospective, Pilot Study”, Dermatol Pract Concept, vol. 14, no. 4, p. e2024259, Oct. 2024, doi: 10.5826/dpc.1404a259.